FDA review of oral MS drug FTY720 extended

If it's on your mind and it has to do with multiple sclerosis in any way, post it here.

FDA review of oral MS drug FTY720 extended

Postby MSUK » Tue May 25, 2010 1:12 am


Novartis International AG / Novartis announces extension of US regulatory priority review period for FTY720, an investigational once-daily oral multiple sclerosis therapy.

* US Food and Drug Administration (FDA) extends priority review period by three months to September 2010, in line with previously announced expectations............. [Read More - http://www.msrc.co.uk/index.cfm/fuseact ... ageid/1309 ]
MS-UK - http://www.ms-uk.org/
User avatar
Family Elder
Posts: 2903
Joined: Wed Oct 14, 2009 3:00 pm


Postby Lo » Tue May 25, 2010 5:15 pm

Thanks for the update.
Family Member
Posts: 33
Joined: Tue Apr 13, 2010 3:00 pm
Location: Florida

Return to General Discussion


  • Related topics
    Last post

Who is online

Users browsing this forum: No registered users

Contact us | Terms of Service